Antisense & RNAi Therapeutics Market Growth 2033

A significant driver in the antisense and RNAi therapeutics market is the ongoing advancements in drug delivery methods. These innovative technologies facilitate the efficient and clean delivery of RNA molecules to targeted cells, helping to prevent degradation and thereby enhancing therapeutic efficacy. For instance, advancements such as lipid nanoparticles and conjugate technologies have dramatically improved cellular uptake and the effectiveness of antisense oligonucleotides and siRNA. This improvement in delivery precision is essential for effectively targeting specific human materials related to conditions like cancer, various disorders, and viral infections.

https://www.imarcgroup.com...